Best Pancreatic Cancer Doctors in Hyderabad — CION's Dedicated Pancreatic Cancer Panel

The best doctor depends on your stage and resectability. For surgery (Whipple procedure or distal pancreatectomy), look for an M.Ch-trained surgical oncologist with HPB experience and a high annual volume of pancreatic surgeries. For borderline-resectable or locally advanced disease, you need a medical oncologist current with neoadjuvant FOLFIRINOX or gemcitabine + nab-paclitaxel protocols. At CION, every pancreatic cancer case is reviewed by a multidisciplinary tumour board, with Whipple procedures led by Dr. Mohammed Imaduddin (M.Ch Surgical Oncology).

A gastroenterologist plays an important role in diagnosis — performing endoscopic ultrasound (EUS) and ERCP, and may place biliary stents when a tumour blocks the bile duct. But once pancreatic cancer is suspected or confirmed, treatment must be led by oncology: a surgical oncologist for resectable disease, a medical oncologist for systemic therapy, and a radiation oncologist where indicated. A general gastroenterologist alone cannot direct pancreatic cancer treatment.

Not necessarily — and a second opinion before accepting this is one of the most important things you can do for pancreatic cancer specifically. Many patients told their cancer is inoperable at a general hospital actually have borderline-resectable disease — which means the tumour touches major blood vessels but could become resectable after neoadjuvant chemotherapy. This distinction matters enormously and many centres do not classify it. CION runs a specific borderline-resectable pathway: structured neoadjuvant chemotherapy, re-staging imaging, and tumour-board re-evaluation before any final decision.

The Whipple procedure (pancreaticoduodenectomy) is the major surgery for cancers in the head of the pancreas. It involves removing the head of the pancreas, part of the small intestine, the gallbladder and bile duct, and sometimes part of the stomach — then reconstructing the digestive tract. It is one of the most complex abdominal surgeries performed. Volume matters more for Whipple than for almost any other cancer surgery — high-volume centres have significantly better outcomes. At CION, Whipple procedures are led by Dr. Mohammed Imaduddin (M.Ch Surgical Oncology).

Borderline-resectable pancreatic cancer is a specific clinical category — the tumour touches or partially involves major blood vessels (superior mesenteric artery, portal vein, hepatic artery), but is not so widely involved as to be definitively unresectable. With several months of neoadjuvant chemotherapy (typically FOLFIRINOX or gemcitabine + nab-paclitaxel), many of these tumours shrink enough to become safely resectable. This is why a second opinion at a specialist centre matters — many general hospitals classify these cases as inoperable when they are not.

For metastatic pancreatic ductal adenocarcinoma, the current NCCN preferred first-line systemic therapies are FOLFIRINOX (or modified FOLFIRINOX) for fit patients and gemcitabine + nab-paclitaxel for those with lower performance status. For BRCA1/BRCA2-mutated advanced PDAC, olaparib maintenance therapy is approved after platinum-based chemotherapy. For pancreatic neuroendocrine tumours (PNETs), separate options exist including somatostatin analogues, everolimus, and sunitinib. CION delivers all current NCCN-preferred regimens.

Yes — current NCCN guidelines recommend germline genetic testing for all patients with pancreatic ductal adenocarcinoma, regardless of family history. Approximately 10% of PDAC cases have a hereditary genetic mutation, most commonly BRCA1, BRCA2, PALB2, ATM, CDKN2A, or Lynch syndrome mismatch repair genes. Identifying these mutations changes treatment (BRCA-mutated PDAC may benefit from olaparib maintenance) and has implications for family screening. CION offers genetic counselling and testing as part of pancreatic cancer care.

A second opinion is especially valuable for pancreatic cancer — both because of the borderline-resectable category that many centres miss, and because Whipple surgery outcomes depend so heavily on surgical volume and team experience. At CION the second opinion is free, written, and yours to keep — our multidisciplinary tumour board reviews your imaging, biopsy, and existing recommendation and provides a documented opinion you can take anywhere, including back to your original doctor.

Costs vary significantly by stage and treatment. The Whipple procedure ranges from approximately ₹4,00,000 to ₹8,00,000+ depending on complexity; distal pancreatectomy ranges ₹2,50,000 to ₹5,00,000; FOLFIRINOX chemotherapy adds substantially over the full course of treatment; olaparib for BRCA-mutated PDAC is higher per month and continues until progression. For a detailed cost breakdown by treatment type, see our pancreatic cancer treatment in Hyderabad page. Every CION patient receives a written, itemised cost estimate before treatment begins. Aarogyasri, EMI, and cashless insurance are accepted.

Yes. When booking your consultation, request a specific doctor by name. For Whipple procedures specifically, Dr. Mohammed Imaduddin leads our pancreatic surgical pathway. We confirm availability and arrange the appointment. Your chosen doctor becomes your named lead specialist for the duration of your care, while other panel specialists join for their part of the journey through the tumour board.